Digital speech biomarkers can measure acute effects of levodopa in Parkinson’s disease

Digital speech biomarkers can measure acute effects of levodopa in Parkinson’s disease

Abstract Speech abnormalities in Parkinson’s disease (PD) are heterogeneous and often considered resistant to levodopa. However, human hearing may miss subtle treatment-related speech changes. Digital speech biomarkers offer a sensitive alternative to measure such changes objectively. Speech was rec...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Sousa, P. Krýže, D. Amstutz, K. Petermann, A. Averna, M. Castelli, A. D. Magalhães, A. Jorge, J. Švihlík, T. Tykalová, V. Illner, M. E. Maradan-Gachet, A. A. Diamantaras, J. Waskönig, M. L. Lachenmayer, I. Debove, G. Tinkhauser, T. Nef, J. Rusz, P. Krack
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-025-01045-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41531-025-01045-5

Similar Items